Serial quantification of minimal residual disease of t(8;21) acute myelogenous leukaemia with RT-competitive PCR assay

British Journal of Haematology

Volumn 95, Issue 1, 1996, Pages 85-94

  Muto, Akihiro ^a   Mori, Shigehisa ^b   Matsushita, Hiromichi ^a   Awaya, Norihiro ^a   Ueno, Hironori ^a   Takayama, Nobuyuki ^a   Okamoto, Shin Ichiro ^a   Kizaki, Masahiro ^a   Ikeda, Yasuo ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

chemotherapy; MAL1 ETO; minimal residual disease (MRD); RT competitive PCR; t(8; 21)

Indexed keywords

CYTARABINE; DAUNORUBICIN; ENOCITABINE; MERCAPTOPURINE; PREDNISOLONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 8; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; MALE; MINIMAL RESIDUAL DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY;

EID: 0029799137     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1877.x     Document Type: Article

References (35)

1. Asou, H., Tashiro, S.,Hamamoto, K., Otsuji, A., Kita, K. & Kumada. N. (1991) Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8:21 chromosome translocation. Blood. 77, 2031-2036.
2. Bae, S.C., Iwai, Y.Y., Ogawa. E., Maruyama, M., Inuzuka. M., Kagoshima, H., Shigesada. K., Satake, M. & Ito, Y. (1993) Isolation of PEBP2αB cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1. Oncogene, 8, 809-814.
3. Becker Andre, M. & Hahlhrock, K. (1989) Absolute mRNA quantilication using the polymerase chain reaction (PCR): a novel approach by a PCR aided transcript titration assay (PATTY). Nucleic Acids Research. 17, 9437-9446.
4. Bennett, J.M., Catavsky, D., Daniel. M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. & Sultan. C. (1985) Proposed revised criteria for the classitication of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Aunals of Internal Medicine. 103, 620-625.
5. Berger, R., Flandrin, G., Bernheim, A., Le Coniat. M., Vecchione, D., Pacot, A., Derre, J., Daniel, M.T., Valensi, F., Sigaux, F. & Ochoa Noguera. M.E. (1987) Cytogenetic studies on 519 consecutive de novo acute nonlymphocytic leukemias. Cancer Genetics and Cytogenetics. 29, 9-21.
6. Chang, K.S., Fan. Y.H., Stass, S.A., Estey. E.H., Wang. G., Trujillo, J.M., Ericson, P. & Drabkin, M. (1993) Expression of AML1. ETO fusion transcripts and detection of minimal residual disease in t(8:21) positive acute myeloid leukemia. Oncogene. 8, 983-988.
7. Cross, N.C.P. (1995) Quantitative PCR techniques and applications. British Journal of Haematology. 89, 693-697.
8. Cross, N.C.P., Feng. L., Chase. A., Bungey. J., Hughes. T.P. & Goldman. J.M. (1993) Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood. 82. 1929-1936.
9. Daga. A., Tighe. J.E. & Calabi. F. (1992) Leukemia/Drosophila homology. Nature. 356, 484.
10. Downing, J.R., Head, D.R., Curcio-Brint. A.M., Hulshof, M.G., Motroni, T.A., Raimondi, S.C., Carroll, A.J., Drabkin, H.A., Willman, C., Theil, K.S., Clvin. C.I. & Erickson. P. (1993) An AML1. ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the t(8:21)(q22:q22) translocation. Blood. 81, 2860-2865.
11. Erickson, P., Gao. J., Chang, K.S., Look. T., Whisenant. E., Raimondi. S., Lusher, R., Trujillo. J., Rowley, J. & Drabkin, H. (1992) Identification of breakpoints in t(8:21) acute myceogenous leukemia and isolation of a fusion transcript. AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood. 80, 1825-1831.
12. Erickson, P.F., Robinson, M., Owens, G. & Drabkin, H.A. (1994) The ETO portion of acute myeloid leukemia t(8:21) fusion transcript encode a highly evolutionarily conserved, putative transcription factor, Cancer Research. 54, 1782-1786.
13. Fenaux, P., Preudhomme, C., Lai. J.L., Morel, P., Beuscart, R. & Bauters, F. (1989) Cytogenetics and their prognostic value in de novo acute myeloid leukaemia: a report on 283 cases. British Journal of Haematology. 73, 61-67.
14. Fukutani, H., Naoe, T., Ohno, R., Yoshida, H., Kiyoi, H., Miyawaki, S., Morishita, H., Sano, F., Kamibayashi, H., Matsue, K., Miyake. T., Hasegawa, S., Ueda, Y., Kato, Y., Kobayashi. H., Shimazaki, C., Kobayashi. M., Kurane, R., Sakota. H., Masaki, K., Wakayama. T., Tohyama. K., Nonaka. Y. & Natori. H. (1995) Prognostic significance of the RT-PCR assay of PML-RARA transcripts in acute promyelocytic leukemia. Leukemia, 9, 588-593.
15. Guerrasio, A., Rosso, C., Martinelli, G., Coco, F.L., Pampinella, M., Santoro. A., Lanza. C., Allione, B., Resegotti. L. & Saglio, G. (1995) Polyclonal haematopoieses associated with long-term persistence of the AML1/ETO transcript in patients with FAB M2 acute myeloid leukaemia In continuous clinical remlssion. British Journal of Haematology. 90, 364-368.
16. Kita, K., Shirakawa, S., Kamada, N., and the Japanese Cooperative Group of Leukemia/Lymphoma (1994) Cellular characteristics of acute myeloblastic leukemia associated with t(8:21)(q22:q22). Leukemia and Lymphoma. 13, 229-234.
17. Kozu, T., Miyoshi, H., Shimizu, K., Maseki. N., Kaneko. Y., Asou. H., Kamada, N. & Ohki. M. (1993) Junctions of the AML1 MTG8 (ETO) fusion are constant in t(8:21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction. Blood. 82, 1270-1276.
18. Kusec. R., Laczica. K., Knobl, P., Friedl. J., Greinix, H., Kahls. P., Linkesch, W., Schwarzinger. I., Mitterbauer. G., Purtscher. B., Haas, O.A., Lechner, K. & Jaeger, C. (1994) AML1 ETO fusion mRNA can be detected in remission blood samples of all patients with t(8:21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation, Leukemia. 8, 735-739.
19. Kwong, Y.L., Path, M.R.C., Chan, V., Wong. K.F. & Chan, T.K. (1995) Use of the polymerase chain reaction in the detection of AML1 ETO fusion transcript in t(8:21). Cancer. 75, 821-825.
20. Lion, T., Izracli. S., Henn. T., Gaiger. A., Mor. W. & Gadner. H. (1992) Monitoring of residual disease in chronic myelogenous leukemia by quantitative polymerase chain reaction. Leukemia. 6, 495-499.
21. Maruyama, F., Stass, S.A., Estey. E.H., Cork, A., Hirano, M., Ino, T., Freireich. E.J., Yang. P. & Chang. K.S. (1994) Detection of AML1 ETO fusion transcript as a tool for diagnosing t(8:21) positive acute myclogenous leukemia, Leukemia. 8, 40-45.
22. Miyamoto, T., Nagafuji, K., Harada, M., Eto, T., Fujlsaki, T., Kubota. A., Akashi, K., Mizuno, S., Takenaka. K., Kanaji. T., Gondo. H., Okamura, T., Inaba. S. & Niho, Y. (1995) Quantitative analysis of AML1/ETO transcripts in peripheral blood stem cell harvests from patients with t(8:21) acute myelogenous leukaemia. British Journal of Haematology, 91, 132-138.
23. Miyoshi, H., Kozu, T., Shimizu, K., Enomoto, K., Maseki. N., Kaneko. Y., Kamada. N. & Ohki, M. (1993) The t(8:21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO Journal, 12, 2715-2721.
24. Mori, M., Muto, A., Ozaki, K., Matsushita, H., Lee, B., Mori, T., Veno. H., Takayama. N., Wakui, M., Watanabe, R., Moriki, T., Yokoyama, K., Ishida. A., Tokuhira. M., Nakajima. H., Michikawa, N., Okamoto, S., Kizaki. M., Ikeda, Y., Asou. H. & Kamada. N. (1994) An experiment on quantification of the minimal residual disease of AML (M2) with t(8:21) by RT-PCR. International Journal of Hematology. 59. (Suppl. 1), 131.
25. Nucifora. G., Birn, D.J., Erickson, P., Gao, J., LeBeau. M.M., Drabkin. H.A. & Rowley. J.D. (1993a) Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1 ETO fusion mRNA in patients with t(8:21) acute myeloid leukemia. Blood, 81, 883-888.
26. Nucifora, G., Larson. R.A. & Rowley. J.D. (1993b) Persistence of the 8:21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood. 82, 712-715.
27. Ogawa, E., Maruyama. M., Kagoshima. H., Inuzuka. M., Lu Jie Satake, M., Shigesada, K. & Ito. Y. (1993) PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proceedings of the National Academy of Sciences of the United States of America. 90, 6859-6863.
28. Ohno, R. et al (1993) Randomized study of individualized induction therapy with or without vincristine. and of maintenanceintensification therapy between 4 or 12 courses in adult acute myeloid leukemia. Cancer. 71. 3888-3895.
29. Rowley, J.D. (1990) Recurring chromosome abnormalities in leukemia and lymphoma. Seminars in Hematology, 27, 122-136.
30. Satake, N., Maseki, N., Kozu, T., Sakashita. A., Kobayashi, H., Sakurai, M., Ohki, M. & Kaneko, Y. (1995) Disappearance of AML1-MTG8 (ETO) fusion trascript in acute myeloid leukaemia patients with t(8:21) in long-term remission. British Journal of Haematology. 91, 892-898.
31. Saunders, M.J., Tobal K. & Liu Yin. J.A. (1994) Detection of t(8:21) by reverse transcriptase polymerase chain reaction in patients in remission of acute myeloid leukemia type M2 after chemotherapy or bone marrow transplantation. Leukemia Research. 18, 891-895.
32. Shimizu, K., Miyoshi, H., Kozu, T., Nagata, J., Enomoto, K., Maseki. N., Kaneko. Y. & Ohki. M. (1992) Consistent disruption of the AML1 gene occurs within a single intron in the t(8:21) chromosomal translocation. Cancer Research, 52, 6945 6948.
33. Swirsky, D.M., Li. Y.S., Malthews, J.G., Flemans, R.J., Rees, J.K.H. & Hayhoe, F.G.J. (1984) 8:21 translocation in acute granulocytic leukaemia: cytological, cytochemical and clinical features, British Journal of Haematology. 56. 199-213.
34. Tighe, J.E., Daga, A. & Calabi, F. (1993) Translocation breakpoints are elustered on both chromosome 8 and chromosome 21 in the t(8:21) of acute myeloid leukemia. Blood. 81, 592-596.
35. Zhang. T., Hillion, J., Tong. J.H., Cao. Q., Chen. S.J., Berger, R. & Chen. Z. (1994) AML-1I gene rearrangement and AML-1-ETO gene expression as molecular markers of acute myeloblastic leukemia with t(8:21). Leukemia, 8, 729 734.